Custom API vs PFI: What Are They?

-

 

custom api

People sometimes find the terms API and PFI a tad confusing. An active pharmaceutical ingredient (API) is an active component of a drug that acts on symptoms of diseases. A pharmaceutical formulation intermediate (PFI), on the other hand, is a mixture of excipients and active substances. 

This article talks about API and PFI. Kindly scroll down and continue reading to learn more. 

What are APIs and PFIs?

Active Pharmaceutical Ingredients work hand in hand with inactive ingredients, which lack direct effects in curing diseases; however, they are required for their production. For instance, an example of an inactive ingredient is dye. It does not heal the body of ailments but is used in pills to give it a particular color.

Custom active pharmaceutical ingredients refer to the major chemical or ingredient that causes a drug to become active. While a Pharmaceutical Formulation Intermediate or a finished formulation is the process by which various chemicals – which include the active ingredients – are blended in specific ratios to produce a particular drug. 

Let us consider the example of an Aspirin 100mg tablet, the active component, or the Active Pharmaceutical Ingredient, the 100mg aspirin. However, in addition to aspirin, the tablet may contain binders, preservatives, fillers, colorants, etc. these ingredients include povidone, soluble starch, stearic acid, starch, maize, and more, which are referred to as Pharmaceutical Formulation Intermediates for their required production. 

API or PFI?

A large pharmaceutical company generally works with about two hundred to two hundred and fifty suppliers worldwide for its Active Pharmaceutical Ingredient formulation. Working with that many suppliers is hard and pricey to run economically. 

Due to the differences in time and cost, along with chaotic supply chain management, most Active Pharmaceutical Ingredient providers are purchasing finished formulation companies, as well as finished formulation companies buying Active Pharmaceutical Ingredient (Custom API) providers, and this results in cross consolidation. 

It has also been noted that working with the major task of Active Pharmaceutical Ingredient cannot make it economically feasible due to high testing and technical costs. 

It is More Profitable to Partner with an External Vendor for PFIs

If big drug manufacturers are looking to save on expenses to limit overspending, they might have to reduce the number of suppliers they partner with. Especially in times like this – COVID-19. However, if there exists a cross consolidation between PFIs and APIs, with regards the supply chain management perspective, they will have no need to partner with several suppliers like earlier. 

Furthermore, many pharmaceutical companies are located in the United States and the United Kingdom, and most PFI and API manufacturers are located abroad. Because dosage producers buy APIs from suppliers and produce PFIs domestically, the cost acquired for its technical production is high, causing their testing cost to increase as well. 

With that being said, drug producers, these days, would rather buy Pharmaceutical Formulation Intermediates from specialized producers to increase the Return on Investment and reduce the cost so that they do not have to make Pharmaceutical Formulation Intermediates domestically and invest in workforce and machinery.

Comments

Post a Comment

Popular posts from this blog

What Is Fill Finish? A Complete Guide to Pharmaceutical Manufacturing

-
Image
Learn what fill finish manufacturing is, how aseptic fill finish works, and why it’s critical for drug safety, sterility, and pharmaceutical quality. Fill Finish Manufacturing: A Complete Guide to Aseptic Drug Fill Finish There is a point in the life of almost every injectable medicine where the science is essentially done — the molecule is right, the formulation is stable, the clinical data is compelling. And then comes fill finish. It is the step most people outside the industry rarely think about, yet it is arguably where everything can go wrong. Fill finish is the process of taking a sterile drug substance and getting it safely into its final container — a vial, a pre-filled syringe, a cartridge, or a flexible bag — sealing it, and sending it to inspection before it ever reaches a patient. Simple to describe. Enormously complex to execute. And, for manufacturers of biologics or any other product that cannot withstand terminal sterilisation, it is the single most contamination-sensi...
Read more

Potent Drug Contract Manufacturing for Safe and Scalable Solid Dose Production

-
Image
Potent Drug Contract Manufacturing for Modern Solid Dose Manufacturing Pharma companies developing high-potency medicines depend on safe, efficient processes. This is where potent drug contract manufacturing   becomes essential. AbbVie supports these complex projects with advanced containment, strict compliance systems, and solid dose manufacturing capabilities designed for high-potency APIs. Introduction to Potent Drug Contract Manufacturing Handling potent APIs requires isolator systems, engineered airflow, and streamlined procedures that protect workers and ensure product quality. As more therapies involve high-potency ingredients, demand continues to grow for partners who can manage solid dose manufacturing with precision and reliability. AbbVie’s platform supports early formulation, scale-up, and full commercial production, giving teams confidence as they advance high-potency compounds through the development lifecycle. Benefits of Potent Drug Contract Manufacturing in Solid D...
Read more

Custom API: Tailored Active Ingredients for Pharma Innovation

-
Image
In the world of pharmaceuticals, one size rarely fits all. That’s where custom API solutions lead the way. Custom APIs—or custom active pharmaceutical ingredients —are the building blocks of targeted, high-performing therapies. These tailored molecules support specific treatment goals, regulatory needs, and delivery systems. Let’s explore why custom API development is key to pharmaceutical success—and how AbbVie helps you scale with precision. What Is a Custom API in Pharma? A custom API is a specially designed active pharmaceutical ingredient. Unlike generic APIs, it’s created with your exact drug formula and delivery system in mind. This means: Enhanced therapeutic performance Better bioavailability Improved patient compliance Stronger intellectual property protection At AbbVie, custom API development is more than synthesis—it's strategy, innovation, and execution. Why Custom Active Pharmaceutical Ingredients Matter In modern drug development, competition ...
Read more